Published in J Clin Microbiol on December 01, 1996
Sensitive method for detection of human herpesviruses 6 and 7 in saliva collected in field studies. J Clin Microbiol (2000) 1.25
Detection of human herpesvirus 6 DNA in serum by a microplate PCR-hybridization assay. J Clin Microbiol (1998) 0.98
Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. J Clin Microbiol (2005) 0.93
Coinfection of human herpesviruses 6A (HHV-6A) and HHV-6B as demonstrated by novel digital droplet PCR assay. PLoS One (2014) 0.92
Detection of human Betaherpesvirinae in saliva and urine from immunocompromised and immunocompetent subjects. J Clin Microbiol (1997) 0.92
Discovery and biological characterization of two novel pig-tailed macaque homologs of HHV-6 and HHV-7. Virology (2014) 0.84
Germ-line transmitted, chromosomally integrated HHV-6 and classical Hodgkin lymphoma. PLoS One (2014) 0.81
Development of a human herpesvirus 6 species-specific immunoblotting assay. J Clin Microbiol (2012) 0.80
Direct Repeat 6 from human herpesvirus-6B encodes a nuclear protein that forms a complex with the viral DNA processivity factor p41. PLoS One (2009) 0.80
No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome. Am J Transl Res (2012) 0.80
Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet (1988) 8.76
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15
Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology (1991) 2.37
Human herpesvirus 6 in salivary glands. Lancet (1990) 2.15
Antibody reactivity with HBLV (HHV-6) in U.S. populations. J Virol Methods (1988) 1.65
Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol (1993) 1.42
Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J Clin Microbiol (1993) 1.34
Human herpesvirus 6: a survey of presence and variant distribution in normal peripheral lymphocytes and lymphoproliferative disorders. J Infect Dis (1994) 1.24
Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro. J Virol Methods (1989) 1.24
Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol (1995) 1.22
Detection of human herpesvirus-6 DNA in peripheral blood and saliva. J Med Virol (1990) 1.17
Variation of DNA sequence in immediate-early gene of human herpesvirus 6 and variant identification by PCR. J Clin Microbiol (1994) 1.09
Seroepidemiological study of human herpesvirus-6 and -7 in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction. J Med Virol (1996) 1.08
Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey. Arch Virol (1994) 1.03
Coinfection with human herpesvirus 6 variants A and B in lung tissue. J Clin Microbiol (1996) 1.02
Serological crossreaction of human herpesvirus-6 with cytomegalovirus. Lancet (1988) 1.01
Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome. J Clin Microbiol (1995) 0.97
Human herpesvirus 6 DNA in blood cells of human immunodeficiency virus-infected men: correlation of high levels with high CD4 cell counts. J Infect Dis (1994) 0.91
High prevalence of HHV-6 DNA in peripheral blood mononuclear cells of healthy individuals detected by nested-PCR. J Med Virol (1994) 0.89
Human herpesvirus-6 DNA in the saliva of paediatric oncology patients and controls. J Med Virol (1995) 0.88
Rate of detection of human herpesvirus-6 at different stages of HIV infection. Eur J Clin Microbiol Infect Dis (1995) 0.88
Geographic/ethnic differences in human herpesvirus-6 antibody patterns. Microbiol Immunol (1992) 0.82
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology (1994) 3.82
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol (1995) 3.67
Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol (2001) 3.58
Cloning and expression of a chitinase gene from the hyperparasitic fungus Aphanocladium album. Curr Genet (1992) 3.24
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Virol (1995) 2.97
Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol (1999) 2.87
Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol (1996) 2.75
Sequencing the termini of capped viral RNA by 5'-3' ligation and PCR. Biotechniques (1991) 2.64
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol (1989) 2.59
Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology (1988) 2.43
Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol (1991) 2.34
Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J Virol (1996) 2.33
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur Respir J (2010) 2.19
The phenomenon of treatment failures in Human African Trypanosomiasis. Trop Med Int Health (2001) 2.18
The flavivirus 3'-noncoding region: extensive size heterogeneity independent of evolutionary relationships among strains of tick-borne encephalitis virus. Virology (1995) 2.08
Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J Gen Virol (1981) 1.90
Flat Refractive Geometry. IEEE Trans Pattern Anal Mach Intell (2011) 1.90
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J Gen Virol (1997) 1.79
Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. Virology (1989) 1.76
Secondary structure of the 3'-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities. RNA (1997) 1.62
A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus. J Biol Stand (1986) 1.62
Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses. Virology (1993) 1.54
A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology (1983) 1.53
Establishment of PCR for the early diagnosis of herpes simplex encephalitis. J Med Virol (1990) 1.50
Loss of a histidine residue at the active site of S-locus ribonuclease is associated with self-compatibility in Lycopersicon peruvianum. Proc Natl Acad Sci U S A (1994) 1.46
Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J Gen Virol (1997) 1.45
Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J Clin Microbiol (1991) 1.38
Human milk oligosaccharides are minimally digested in vitro. J Nutr (2000) 1.35
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers. Vaccine (1990) 1.35
Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol (1996) 1.34
Near-patient assays for diagnosis of influenza virus infection in adult patients. Clin Microbiol Infect (2009) 1.32
Viral diagnoses using the rapid immunofluorescence technique and epidemiological implications of acute respiratory infections among children in different European countries. Bull World Health Organ (1984) 1.31
Characterization and complete genome sequences of high- and low- virulence variants of tick-borne encephalitis virus. J Gen Virol (1996) 1.28
Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers. J Infect Dis (1980) 1.27
Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med (1999) 1.26
Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine (1995) 1.26
Reconstruction of orbital wall defects: critical review of 72 patients. Int J Oral Maxillofac Surg (2007) 1.24
Antibody-induced conformational changes result in enhanced avidity of antibodies to different antigenic sites on the tick-borne encephalitis virus glycoprotein. Virology (1984) 1.23
Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus. J Virol (2001) 1.23
Expression of cloned envelope protein genes from the flavivirus tick-borne encephalitis virus in mammalian cells and random mutagenesis by PCR. Virus Genes (1994) 1.21
The interactions of the flavivirus envelope proteins: implications for virus entry and release. Arch Virol Suppl (1994) 1.20
Chemical crosslinking of tick-borne encephalitis virus and its subunits. J Gen Virol (1980) 1.19
A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J Virol (1990) 1.19
A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J Immunol (1999) 1.17
Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tick-borne encephalitis virus in serum and cerebrospinal fluid. J Clin Microbiol (1981) 1.17
Silencing of transgenes introduced into leaves by agroinfiltration: a simple, rapid method for investigating sequence requirements for gene silencing. Mol Gen Genet (1997) 1.16
Studies in man with cold-recombinant influenza virus (H1N1) live vaccines. J Med Virol (1980) 1.16
Detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay, indirect immunofluorescence, and virus isolation: a comparative study. J Med Virol (1986) 1.15
Repair of complex orbital fractures: technical problems, state-of-the-art solutions and future perspectives. Ann Acad Med Singapore (1999) 1.15
Improved detection of respiratory syncytial virus in nasal aspirates by seminested RT-PCR. J Med Virol (1997) 1.14
Presence of poly(A) in a flavivirus: significant differences between the 3' noncoding regions of the genomic RNAs of tick-borne encephalitis virus strains. J Virol (1991) 1.14
Tick-borne encephalitis virus envelope protein E-specific monoclonal antibodies for the study of low pH-induced conformational changes and immature virions. Arch Virol (1995) 1.13
Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev. Virology (1991) 1.12
Serological diagnosis of acute tick-borne encephalitis by demonstration of antibodies of the IgM class. J Med Virol (1981) 1.12
Nephropathia epidemica and Puumala virus in Austria. Eur J Clin Microbiol Infect Dis (1999) 1.10
Characterization of a disulphide bridge-stabilized antigenic domain of tick-borne encephalitis virus structural glycoprotein. J Gen Virol (1987) 1.10
Contribution of rhinoviruses to respiratory viral infections in childhood: a prospective study in a mainly hospitalized infant population. J Med Virol (1988) 1.09
Inhibitory effects of phytic acid and other inositol phosphates on zinc and calcium absorption in suckling rats. J Nutr (1989) 1.09
Identification of tick-borne encephalitis virus ribonucleic acid in tick suspensions and in clinical specimens by a reverse transcription-nested polymerase chain reaction assay. Clin Diagn Virol (1995) 1.09
The msh2 gene of Schizosaccharomyces pombe is involved in mismatch repair, mating-type switching, and meiotic chromosome organization. Mol Cell Biol (1999) 1.07
Boosting properties of recombinant DNA hepatitis B vaccine. Lancet (1986) 1.07
Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene (1997) 1.07
Immunopeptides in the defense reactions of Glossina morsitans to bacterial and Trypanosoma brucei brucei infections. Insect Biochem Mol Biol (2002) 1.07
Investigations of the in vitro transport of human milk oligosaccharides by a Caco-2 monolayer using a novel high performance liquid chromatography-mass spectrometry technique. J Biol Chem (2001) 1.05
Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents. Ann Oncol (2014) 1.05
Tick-borne encephalitis and the impact of vaccination. Arch Virol Suppl (2004) 1.03
Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol (1990) 1.03
Early detection of acute rhinovirus infections by a rapid reverse transcription-PCR assay. J Clin Microbiol (2001) 1.03
Evaluation of the polymerase chain reaction for diagnosis of herpes simplex virus encephalitis. J Clin Microbiol (1993) 1.02
Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants. Clin Exp Immunol (2004) 1.02
Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. J Infect Dis (2000) 1.02
Studies on the glycosylation of flavivirus E proteins and the role of carbohydrate in antigenic structure. Virology (1987) 1.02
Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Haematol (1992) 1.02